Craig-Hallum Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating
Phathom Pharmaceuticals (PHAT) Gets a Buy From Craig-Hallum
Earnings Preview: PHAT to Report Financial Results Pre-market on November 07
Investors Bid Phathom Pharmaceuticals (NASDAQ:PHAT) up US$75m Despite Increasing Losses YoY, Taking One-year Return to 96%
Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024
Express News | Reported Earlier, Phathom Pharmaceuticals To Reveal VOQUEZNA Data At The American College of Gastroenterology 2024 Annual Meeting
